Quantcast
Home / Opinions / Opinion Digest / Vioxx suit improperly certified as class action

Vioxx suit improperly certified as class action

A product liability suit concerning the pain killer Vioxx could not be certified as a class action under a “fraud-on-the-market” theory of liability, the Kentucky Court of Appeals has ruled in reversing judgment.